Capture DNA RNA Synthesis for Low dsRNA Impurities
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing RNA produce significant amounts of double-stranded impurities, which trigger an unwanted innate immune response in patients, posing a safety risk, especially in mRNA therapeutics.
Innovation Solution
The use of capture DNA complementary to the 3' end of the product RNA, covalently or noncovalently attached to a solid support, to inhibit self-primed extension and purify the RNA, combined with high salt conditions or flow reactors to enhance purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If T7 RNA polymerase is used for high yield RNA synthesis, then productivity is improved, but double-stranded impurities are generated that trigger immune responses
Solution Approach 1:
The harmful double-stranded RNA impurities are selectively removed from the reaction mixture through purification steps, separating the desired single-stranded RNA product from the harmful byproducts generated by T7 RNA polymerase activity
Solution Approach 2:
Reaction conditions are optimized by adjusting parameters such as salt concentration, temperature, and pH to favor single-stranded RNA production while minimizing the formation of double-stranded impurities during transcription
2Manufacturing precision
If extensive purification is performed to remove impurities, then purity is improved, but manufacturing complexity increases
Solution Approach 1:
The reaction conditions are预先 optimized to minimize impurity formation during the synthesis step itself, reducing the burden on subsequent purification steps and simplifying the overall manufacturing process
Solution Approach 2:
Intermediate purification steps are designed to selectively remove specific types of impurities at strategic points in the process, making the overall purification train more efficient and less complex than attempting single-step removal of all impurities
3Reliability
If mRNA is used for gene replacement therapy, then therapeutic potential is improved, but innate immune response increases causing safety risks
Solution Approach 1:
The knowledge that certain modifications reduce immune recognition is used to design mRNA molecules with altered nucleotide sequences or chemical modifications that maintain therapeutic function while evading the innate immune system that would otherwise recognize and destroy them
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly reduces double-stranded RNA impurities, improving the safety and efficacy of RNA therapeutics by minimizing immune responses.
Implementation Method 1
the capture DNA is complementary to 8 to 20, preferably 12 to 20 nucleotides at the 3' end of the product RNA
Implementation Method 2
an RNA polymerase and a capture DNA under conditions for product RNA synthesis
Data Source
AI summary
Described herein are synthetic methods for producing sequence-specific RNA oligonucleotides that eliminate impurities produced in prior art methods. In one aspect, an end-protected capture DNA complementary to a portion of the product RNA is employed. In another aspect, the template DNA is covalently or noncovalently linked to the RNA polymerase, either directly or through the use of a nontemplate DNA. In a third aspect, a flow chamber is employed. All of the methods can be used in combination.